<unk> + T<unk>  promote anti-tumor immunity through numerous mechanisms, including enhancing antigen presentation, co-stimulation, T<unk> homing, T<unk> activation, and effector function. These effects are mediated at sites of T<unk> priming and at the tumor microenvironment. Several cancer<unk>  approaches induce durable<unk> + T<unk> responses and have promising clinical activity. This kind of<unk>  can be realized by DNA recombinant fusion proteins expressed in E. coli. The protein MAGE-3 has already been used in lung cancer treatment and has received positive feedback.
Cancer vaccine targeting CD4+ T cells
Dendritic cell-based cancer vaccine
Tumor antigen vaccine
T cell receptor T cell therapy
Individualized cancer immunotherapy
Active immunotherapy
T-cell vaccination
Vaccine therapy